David R. Stern is listed as an executive officer and director on 10 SEC Form D filings by 3 issuers between Apr 2009 and Apr 2023: CARDIOMEMS INC (Atlanta, GA — other health care — 2009–2010; $60M reported sold to 94 investors), CONTEGO MEDICAL INC (Raleigh, NC — other health care — 2020–2023; $23M reported sold to 31 investors) and ARTERAIN MEDICAL INC (Atlanta, GA — biotechnology — 2009–2010; $625K reported sold to 3 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer and director, over about 14 years. Across those companies the filings report $83.6M sold in total.
Listed alongside Marvin L. Woodall (8 shared filings), Jay S. Yadav (7 shared filings), Daniel H. Bauer (5 shared filings), John Huntz, Jr. (5 shared filings), Lee R. Wrubel (5 shared filings) and 20 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around David. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 6 SEC releases, 7 bankruptcy cases matching the name listed in Key records below.
What this means 13 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 10 public filings for David R. Stern and found 8 differences, 1 worth asking the sponsor about: Form D filed 81 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.